Diabetes Care：姜黄成分降低2型糖尿病的发病率

最新研究证实姜黄素中一种成分可以降低2型糖尿病的发病率，改善成年人糖尿病前期β细胞的功能，相关研究论文发表在<em>Diabetes Care</em>杂志上。
<p align="center"><img src="http://www.bioon.com/biology/UploadFiles/201207/2012071312210059.jpg" alt="" width="185" height="185" border="0" /></p>
医师Somlak Chuengsamarn与同事随机分配240例糖尿病前期成人口服姜黄素或安慰剂，每天两次共接受九个月治疗。治疗后对这些人2型糖尿病进展进行了评估分析。

<!--more-->

九个月后，研究人员发现16.4％的安慰剂组患上了糖尿病，姜黄素组无一人患2型糖尿病的。姜黄素治疗后能显著改善β细胞的功能。

总之结论支持：一个糖尿病前期患者服用9个月的姜黄素能显著降低患2型糖尿病的风险。此外，姜黄素治疗能改善β细胞的整体功能，而姜黄素的不利影响却非常少。

泰国政府制药组织为这项研究提供了姜黄素提取物和安慰剂。
<div id="ztload">
<div>
<div>

<img src="http://www.bioon.com/biology/UploadFiles/201207/2012071312190383.gif" alt="" width="115" height="150" border="0" />

<a title="" href="http://dx.doi.org/10.2337/dc12-0116" target="_blank">doi:10.2337/dc12-0116</a>
PMC:
PMID:

</div>
<div>

<br/><strong>Curcumin Extract for Prevention of Type 2 Diabetes</strong><br/>


Somlak Chuengsamarn, MD1,2, Suthee Rattanamongkolgul, MD3, Rataya Luechapudiporn, PHD4, Chada Phisalaphong, PHD5 and Siwanon Jirawatnotai, PHD6,7
<p id="p-2"><br/><strong>OBJECTIVE</strong><br/>
To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetes population.</p>

<div id="sec-2">
<p id="p-3"><br/><strong>RESEARCH DESIGN AND METHODS</strong><br/>
This randomized, double-blinded, placebo- controlled trial included subjects (<em>n</em> = 240) with criteria of prediabetes. All subjects were randomly assigned to receive either curcumin or placebo capsules for 9 months. To assess the T2DM progression after curcumin treatments and to determine the number of subjects progressing to T2DM, changes in β-cell functions (homeostasis model assessment [HOMA]-β, C-peptide, and proinsulin/insulin), insulin resistance (HOMA-IR), anti-inflammatory cytokine (adiponectin), and other parameters were monitored at the baseline and at 3-, 6-, and 9-month visits during the course of intervention.</p>

</div>
<div id="sec-3">
<p id="p-4"><br/><strong>RESULTS</strong><br/>
After 9 months of treatment, 16.4% of subjects in the placebo group were diagnosed with T2DM, whereas none were diagnosed with T2DM in the curcumin-treated group. In addition, the curcumin-treated group showed a better overall function of β-cells, with higher HOMA-β (61.58 vs. 48.72; <em>P </em>&lt; 0.01) and lower C-peptide (1.7 vs. 2.17; <em>P </em>&lt; 0.05). The curcumin-treated group showed a lower level of HOMA-IR (3.22 vs. 4.04; <em>P </em>&lt; 0.001) and higher adiponectin (22.46 vs. 18.45; <em>P </em>&lt; 0.05) when compared with the placebo group.</p>

</div>
<div id="sec-4">
<p id="p-5"><br/><strong>CONCLUSIONS</strong><br/>
A 9-month curcumin intervention of a prediabetes population significantly lowered the number of prediabetic individuals who eventually developed T2DM. In addition, the curcumin treatment appeared to improve overall function of β-cells, with very minor adverse effects. Therefore, this study demonstrated that the curcumin intervention in a prediabetes population may be beneficial.</p>
<br/>来源：生物谷

</div>
</div>
</div>
</div>